Home › Funds › WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC › ABT

WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC position in ABT

ABBOTT LABORATORIES · Health Care

WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC reported holding 604,290 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$59.7M, representing 3.02% of its reported portfolio and ranking #13 among its reported holdings. WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)604.29K sh
Reported value held$59.72M
Portfolio Weight3.02%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC's ABT position evolved

WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC first disclosed a stake in ABT in Q3 2023 at 4,555 shares (US$441K). The position peaked in Q1 2026 at 643,571 shares, worth US$66.1M. Across 13 filings, WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 604,290 shares valued at US$59.7M — an increase of 148,742 shares quarter over quarter.. Notable position changes include a 14531% increase in Q3 2025 (shares fell 6% over the following quarter), a 42% increase in Q1 2026 (shares fell 11% over the following quarter), a 33% increase in Q3 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.55K $441.15K New
Q4 2023 4.02K $442.92K Reduce
Q1 2024 3.87K $440.21K Reduce
Q2 2024 3.25K $337.92K Reduce
Q3 2024 3.25K $370.76K Hold
Q4 2024 3.25K $367.83K Hold
Q1 2025 3.25K $431.38K Hold
Q2 2025 3.12K $424.62K Reduce
Q3 2025 456.77K $61.18M Add
Q4 2025 452.95K $56.75M Reduce
Q1 2026 643.57K $66.08M Add
Q2 2026 455.55K $41.34M Reduce
Q3 2026 604.29K $59.72M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC held ABT?

WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC's current position in ABT?

As of Q3 2026, WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC holds 604.29K shares of ABT (ABBOTT LABORATORIES), valued at $59.72M, representing 3.02% of its reported portfolio and ranking #13.

Has WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC been buying or selling ABT?

In the latest 13F filing (Q3 2026), WOODLEY FARRA MANION PORTFOLIO MANAGEMENT INC increased its position in ABT. The position peaked in Q1 2026 at 643.57K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.